OpenAI says it trained a new AI model called GPT-4b micro with Retro Biosciences, a longevity science startup trying to extend the human lifespan by 10 years, according to the MIT Technology Review.
Retro, which is backed by Sam Altman, has been working with OpenAI for roughly a year on this research, according to the report. The GPT-4b micro model tries to re-engineer proteins — a specific set called the Yamanaka factors — that can turn human skin cells into young-seeming stem cells. Retro believes these proteins are a promising step toward building human organs and providing supplies of replacement cells.
The model differs slightly from Google’s Nobel prize-winning AlphaFold, which predicts the shape of proteins, but it appears to be OpenAI’s first model that is custom-built for biological research. OpenAI and Retro tell the MIT Technology Review they plan to release research on the model and its outputs.
You Might Also Like
Google changed the Gulf of Mexico to the Gulf of America on Maps
Google Maps officially updated the name of the Gulf of Mexico to the Gulf of America on Monday. Among many...
Apple and Google take down malicious mobile apps from their app stores
Apple and Google have pulled as many as 20 apps from their respective app stores after security researchers found the...
These are the investors funding Musk’s $97 billion OpenAI takeover attempt
As if Elon Musk doesn’t have enough going on, a consortium of investors led by him announced plans Monday for...
Is AI making us dumb?
Researchers from Microsoft and Carnegie Mellon University recently published a study looking at how using generative AI at work affects...